RAFIQUE M ISLAM, M.D., Ph.D.
Technical Manager/Health Physicist
Naval Dosimetry Center
Walter Reed National Military Medical Center
Bethesda, MD 20889
*******.*.*****.***@******.***
MANAGEMENT AND RESEARCH STATEMENT
A career physician-scientist-physicist highly experienced in clinical medicine, science and management of science, operation and production teams seeking a leadership position where contributions will be made with the highest professionalism and efficiencies. PROFILE
A result driven accomplished manager with proven track record of leading an organization with the federal government. Independently conducted basic and translational research at the National Institute of Health (NIH) and Naval Medical Research Center (NMRC). Led a spirited team of experts in dosimetry and health physics serving the radiation health programs of 155 Bureau of Medicine and Surgery (BUMED) commands and 12 Naval Nuclear Propulsion Program (NNPP) commands. Provide technical and scientific expertise to internal personnel and external clients. Ensure to consistent adherence to and compliance of all Navy and Federal regulatory guidelines applicable to radiation health programs and qualify the Naval Dosimetry Center (NDC) successful completion of National Voluntary Laboratory Accreditation Program
(NVLAP) and BUMED/Naval Reactors audits. A multi-disciplinary expert capable of accomplishing the most challenging of assignments and recognized by senior managers, partners and external customer commands. Proven leader with the ability to identify and capitalize on individual strengths, motivate teams and implement vision to achieve organization’s goals on the highest level. Core competencies include: Leadership & Execution Strategy Development Innovation Business Process Improvement Results Driven Building Coalitions SELECTED ACCOMPLISHMENTS
Led innovative business processes at the Federal workplaces to keep pace with the technological advancements and ever-increasing demands from stakeholders.
• Served as the leader of a team of physiologists to quantify the roles of environmental factors on the performance and health of the Navy personnel and tested therapeutic modalities to sustain the mission goals.
• Provide leading technical and administrative expertise to the NDC for the United States Navy.
• Provide training in health physics and dosimetry to NDC staffs.
• Lead development and performance of research in radiobiology and dosimetry at NDC.
• Organized, operated and managed scientific and administrative programs at the Department of Veteran Affairs (VA).
• Delivered speeches in International scientific conferences including Neuroscience Society and American Heart Association (ATVB) meetings.
• Independently developed and conducted research in lipoproteins at the National Health of Institute
(NIH).
• Independently developed and conducted research in neuroscience at academic laboratories
• Designed and wrote research protocols and acquired approvals from the Institutional Animal Care and Use Committee (IACUC) and Institutional Review Board (IRB) at NIH.
• Organized and moderated scientific meetings, panel discussions, including Gordon Research Conferences (2018), Annual Career Symposium of the NIH (2019).
• Established scientific communications with both domestic and international peers and major research stakeholders.
• Authored 20 articles in high impact journals on biomedical research, Military medicine, basic, and data sciences, innate immunity, developmental neurobiology, neurotoxicology, G-protein coupled receptor (GPCR) mediated cell signaling, lipoprotein metabolism and metabolic diseases.
• Published articles in prestigious book series released by the American Chemical Society
• Served as a Scientific Review Officer (SRO) at the Office of Scientific Review (OSR) of the National Center for Complementary and Integrative Health (NCCIH) at NIH, organized and managed the review panel of NCCIH’s training grant applications. Served in Review Panels and produced summary statements of the panel discussions.
• Served as an Invited reviewer to 7 (seven) international peer reviewed journals.
• Mentored undergraduate and graduate students at NIH and academic laboratories
• Demonstrated advanced knowledge and skills in Microsoft Office programs and a list of government approved digital programs
• Applied advanced knowledge and skills in statistical programs to analyze results and making predictions
PROFESSIONAL EXPERIENCE
Technical Manager/Health Physicist July 2022-Present
$121,898 per annum 40 hours per week
GS-1306-13-02
Naval Dosimetry Center
Naval Medical Research Center
Walter Reed National Military Medical Center
Department of Navy
975 North Palmer Road
Bethesda, MD
Supervisor: Jessica L Saunders 405-***-****
(May be contacted)
Served as the leading Research Physiologist at the NMRC and investigated undersea environments on the health of the submarine crews and divers. Presently serve as the Technical Manager of the Naval Dosimetry Center, lead a team of 32 employees and contractors in the performance of dosimetry for 155 BUMED and 12 NNPP commands. These services impact sixty thousand (60,000) Sailors, Marines, and Civilians annually across commands globally. Responsible for providing dosimetry and radiation health expertise to the staffs and external clients. Oversees all phases of integration of new technologies and decommissioning of the same. Ensures compliances of the Navy and Federal guidelines for radiation health protection. Provide briefings and advice to senior officials at NDC, including the Officer in Charge, on such matters as detailed Semi-annual Trend analysis, Comments and recommendations by the NVLAP and BUMED auditors. Attained Secret clearance. Key accomplishments include the following:
• Led a group of physiologists to investigate the impacts of undersea environments on the health of the sailors and divers by using pigs and hyperbaric chambers.
• Provide technical direction and leadership to NDC’S primary operations.
• Serve as the designated Signatory being the terminal authority and responsible to review all signed dosimetry reports. Responsible for the accuracy, quality, and archiving of dosimetry records and reports to Navy Commands.
• Ensure the dosimetry system meets the Federal, Navy and other appropriate standards.
• Ensure that the NDC Operations Department operates in accordance with the Operations and Quality and Technical Manual based on Navy guidelines.
• Assist the Quality Manager in conducting internal audits to identify discrepancies and deficiencies.
• Establish short term plans for Navy Dosimetry.
• Coordinate with the Science Research Advisor (SRA) in performing intra and inter agency dose comparisons.
• Check and/or re-establish new reference light values for the DT-702 (whole body) and DT-707
(extremity) 8800 absorbed radiation readers.
• Perform calibration checks on radioactive sources used for dosimetry processing.
• Perform investigations to determine the cause of abnormal dosimeter response.
• Test and evaluate new dosimeters before adding them to the Navy dosimetry system.
• Assist the SRA in evaluating new dosimetry modalities.
• Perform committed effective dose equivalent calculations.
• Conduct relevant research to improve current/future U.S. Navy dosimetry systems.
• Develop research projects on radiation and advise the leadership about scientific innovations and integration to the operation of the Center.
• Write memos for internal staffs and external clients updating guidelines and services.
• Prepare NDC for audits by regulatory bodies and assist the auditors to conduct inspections freely and without interference.
• Provide training to internal staffs on Health Physics and Dosimetry.
• Represent NDC to government and industry meetings. Health Science Specialist June 2021-July 2022
$87,327 per annum 40 hours per week
GS-0601-12-01
Department of Veterans Affairs
Research and Development Service
Veterans Affairs Medical Center
Ann Arbor, MI
Supervisor: Dr. Krishna Murthy 434-***-****)
(May be contacted)
As a Health Science Specialist, navigated Million Veteran Program (MVP) sponsored databases to retrieve data on veterans’ health. Oversaw and managed cleansing, storage, analysis of research data for over $7,000,000 (seven million) projects. Applied statistics to make predictions on the trends of pulmonary cancers among the veterans. Monitored outcomes of treatment therapy and analyze the successes of the therapeutic modalities. Collaborated with the interinstitutional scientists and administrators. Reported the research outcomes at meetings with senior scientists and officials. Led analyses of proposed budget and program actions and advised management of alternative courses of action. Assisted the Division Director in the presentation and justification of the research budget to agency leadership of the Department of Veterans’ Affairs. Key accomplishments included the following:
• Data analyst for Lung Precision Oncology Program (LPOP) covering the lung cancer screening programs in the VISN10 AND VISN12 Medical Centers.
• Clinical Chart reviews from the Corporate Data Warehouse (CDW) for large scale studies.
• Provided support on standing ad hoc areas of responsibility, including in the areas of program representation, basic negotiation, marketing, compliance, and scientific fidelity.
• Reviewed long-and short-range plans, resource projections, priorities, and justifications.
• Managed projects, facilitated communications, researched operational and regulatory requirements.
• Led industry partners based on experience and expertise regarding use of confidential Disclosure Agreements (CDAs) and Cooperative Research and Development Agreements (CRADAs).
• Consulted with VA legal officers on issues arising when there were missing that are not detailed in existing Standard Operation Protocols (SOPs).
• Managed a portfolio of assigned activities that includes record management related to progress, outcomes of overall key details that support broader program goals
• Advised on budgetary/financial requirements and processes for the proper conduct of clinical studies.
• Communicated and prepared documents and materials in support of the communications on study activities or challenges that require action and support.
• Collected and analyzed key metrics related to program performance and adherence to program's SOPs.
• Reviewed project data to prepare reports on trends and alerts related to industry engagement, studied start up timelines, and issues impacting or significantly delaying projected performance. Graduate Partnership Program Researcher June 2015-June 2018
$39,514 per annum 40 hours per week
Postdoctoral Fellow July 2018- June 2021
$64,205 per annum 40 hours per week
National Institutes of Health (NIH)
National Heart Lung and Blood Institute (NHLBI)
9000 Rockville Ave
Bethesda, MD
Supervisor: Dr. Alan Remaley 301-***-****)
(May be contacted)
As a graduate student at George Mason University (GMU) and a researcher of the National Institute of Health (NIH) joint Graduate Partnership Program (GPP), conducted thesis research at NIH. Graduate research focused on Heart Health by developing new treatment modalities for hypercholesteremia. Post- graduate activities at NIH included research and management of scientific projects. This tenure yielded publication of multiple high impact papers, developed managerial skills and implanted aspirations to lead. Selected achievements of the tenure are following:
• Served as the manager of the multi-institutional fundamental science-epidemiological projects worth of over $15 (fifteen) million. Conducted statistical data analysis, prepared reports for publication.
• Conducted large scale observational study with 2000 participants along with biological projects using laboratory methods.
• Developed a method on isolation, culture, and assay of human NK cells to discover the pathways involving cytotoxicity to target cells.
• Developed a new method to quantify the impacts of cytokines on fibrocytes of patients with Graves' orbitopathy (GO). This method now allows measuring both hyaluronic acid (HA) secretion and mRNA of hyaluronic acid (HA) synthase (HAS) concurrently from the same assay, thus saves time (50%) and resources.
• Identified one of the three HAS genes (HAS1, HAS2, HAS3) responsible for the upregulation of HA synthesis. This discovery helps to target HAS2 for therapeutic purposes.
• Identified a small molecule that can ameliorate inflammatory process of fibroblast by inhibiting cytokine IL-1 beta.
• Dissected a complex signaling pathway driving the secretion of HA from fibroblast undergoing transformation. Performed extensive analysis of biochemical players in this pathway and their contribution to GO pathogenesis.
• Developed reports on results and led group meetings to discuss findings. Prepared summary of the recommendations by the lab members.
• Designed and developed High Density Lipoprotein (HDL) mimetic peptides and tested in cellular systems. Simulated the functions of these peptides using computer programs.
• Applied various state-of-the-art and high throughput methods such as MALDI-TOF, FPLC classes of mass- spectroscopy for collection of large-scale data on protein properties.
• Proposed, planned, and moderated career development workshop for graduate students and postdoctoral fellows at NIH.
• Represented the laboratory at Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) meeting in Minneapolis and in Gordon Conference in New Hampshire.
• Organized and moderated a journal club for NIH Summer Student Interns and served as the Selector for High School Students to NIH Summer Internship Program.
• Served as an External Adviser on a Masters’ Thesis Committee at the George Mason University.
• Published 5 (five) research papers, and 9 (nine) abstracts. Presented 7 (seven) posters at national and international meetings and conferences.
Postdoctoral Fellow January 2000- June 2014
$29,000-46,000 per annum 40 hours per week
University of Michigan
Ann Arbor, MI
University of Florida
Gainesville, FL
Supervisors: Dr. Michael Hortsch 434-***-****)
Dr. Jeffrey Bloomquist 352-***-****)
(Both may be contacted)
As a Postdoctoral Fellow at academic universities, conducted research in the fundamental neurosciences. The research areas ranged from basic understanding of the nervous system development in simple fruit fly
(Drosophila melanogaster) to application of neurotoxicity principles in the mosquito (Anopheles gambiae) for developing anti-malarial agents. These tenures enriched and broadened the clinical understanding of health and its pathology. Widely published in respected journals and served as an invited reviewer of peer- authored articles. Built expanded networks in the scientific communities and established national and international collaborations. The following are a few selected achievements:
• Conducted research in neurotoxicology and insect physiology. Designed over 200 chemical compounds and tested those in mosquito toward development of sustainable insecticides for the control of malaria vector and coordinated research projects by other scientists in the lab.
• Supervised a BioSafety level 3 laboratory (BSL3) facility.
• Worked closely with the Center for Disease Control (CDC) scientists toward testing of chemical compounds on the mosquito, Anopheles gambiae.
• Applied expertise in electrophysiology and insect physiology to test the effects of insecticide on mosquito nervous system.
• Studied the roles of sialyation in the development of nervous system using electrophysiology on Drosophila melanogaster. The results demonstrated the role of Drosophila cytidine monophosphate-sialic acid synthetase in the nervous system.
• Studied the neuroprotective roles of mitochondrial uncoupling protein 2 (UCP2) in a Drosophila model of Parkinson’s Disease. The results demonstrated that Drosophila model of Parkinson Disease expressing UCP2 preserved higher number of dopaminergic neurons and higher motor activities.
• Investigated the role of environmental factors in the pathogenesis of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and demonstrated that non-specific protein ss-N- methylamino-L-alanine (BMAA) caused ALS-like phenotypes. Pathogenesis of ALS was deciphered.
• Taught a course on electrophysiology at the symposium ‘Developmental Neurobiology’ organized at the Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
• Studied the role of L1-type cell adhesion molecules (LCAM) in the development of nervous system particularly cell migration, adhesion, and neurite outgrowth. Demonstrated that EGF-R activation was required for dimerization of LCAM which is a requirement for cell-cell adhesion.
• Published 15 (fifteen) research papers, 2 (two) book chapters, and 32 (thirty-two) abstracts. Presented 28 (twenty-eight) posters at national and international meetings and conferences.
• Trained 3 Ph.D and 5 Masters’ students.
Attending Physician July 1991- August 1999
Medical Resident 40 hours per week
$30,000-50,000 per annum
Dhaka Postgraduate Hospital
Department of Gastrointestinal and Kidney Diseases 20019 Elephant Road
Dhaka, Bangladesh
Moscow State University of Medicine and Dentistry, Russia Department of Internal Diseases
525 Delegatskaya Ulitsa
Moscow, Russia
Supervisors: Dr. Ahmed Faruque +88-017******)
Dr. Sergei Khodin +7-095-*******)
(Both may be contacted upon availability)
As an Attending Physician and Medical Resident in high-capacity hospitals, examined, diagnosed, treated and managed patients, primarily in the areas of general medicine (Internal Medicine). Oversaw medical residency program, trained medical residents and taught a course on Gastrointestinal disease. Lobbied for funding for building a new hospital, acquired grants, served as an executive board member for the new hospital.
EDUCATION
• Doctor of Philosophy (Ph.D.) – Cellular and Molecular Biology School of Systems Biology 2014-2018
George Mason University GPA: 3.9/4
National Institutes of Health Honors: Summa cum laude Thesis Advisor – Dr. Alan Remaley 301-***-****)
(May be contacted)
• Doctor of Medicine (M.D.) 1985-1991
Moscow State University of Medicine and Dentistry GPA: 4.7/5 Moscow, Russia Honors: President’s Honor List
RELEVANT COURSES
• Spring Technical Manager/Quality Manager Training 2024 NAVSHIPYD, Puget Sound, WA
• Health Physics Courses 2024
IRPA 16 HPS Conference
Orlando, Florida
• MIRION Connect 24 Training
Course: Applied Principles of Gamma Spectroscopy 2024 Dallas, TX
PROFESSIONAL MEMBERSHIPS
• Health Physics Society, Member 2022-Present
• Member of the Advisory Board 2017-2021
School of Systems Biology
George Mason University
AWARDS AND ACHIEVEMENTS
• NIH SACNAS Professional Chapter Award 2017
• NIH Graduate Partnership Program Award 2017
• George Mason University Graduate Fellowship 2016
• NIH Summer Student Fellowship Award 2016
• George Mason University Graduate Director Award 2014
• Fine Science Tools Travel Fellowship for attending
• The Society for Neuroscience meeting, Atlanta, GA 2006
• Scholarship for the study of Medicine. The Government 1984
• of the Union of the Soviet Socialist Republic
TEACHING EXPERIENCES
• Weekly classes on Health Physics 2024-Present
Naval Dosimetry Center
• General Genetics (BIOL 311-****-****
George Mason University,
• Advances and Challenges of Protein Purification 2016 Invited Lecturer,
George Mason University
• External Adviser to master’s Thesis Committee 2018-2019 Student: Michael Landivar.
School of Systems Biology
George Mason University
• Neurobiology of Drosophila 2008
Cold Spring Harbor Laboratories, NY,
ADMINISTRATIVE SERVICES
Institutional Service
• Served as a trainee in National Center for Complementary and Integrated Health (NCCIH/NIH). Planned, organized, and managed NIH grant Scientific Review Panel, 2020.
• Moderator Technology Transfer & Patent Careers Annual Career Symposium National Institutes of Health, 2019.
• Mentor, Journal Club for Summer Interns ‘From Bench to Bed’ National Institutes of Health, 2019.
• President, School of Systems Biology Graduate Students’ Organization, 2015-2018. National Service
• Invited Reviewer Molecular Biology Moscow (Springer, 1 article), 2018.
• Invited Reviewer Computational Biology and Chemistry (1 article), 2017.
• Invited Reviewer African Journal of Biotechnology (1 article), 2014.
• Invited Reviewer Toxicology Letters (1 article), 2014.
• Invited Reviewer Pest Management Science (1 article), 2013.
• Invited Reviewer Toxicology Letters (1 article), 2012.
• Invited Reviewer Pest Management Science (1 article), 2012. MAJOR PROFFERED COMMUNICATIONS
• Islam R, Gutierrez-Huerta C, Turner B, Mitchell V, Collins B, Baumer Y, Powell-Wiley, Y. Obesity-related and LDL-mediated loss of NK cell degranulation and cytotoxocity is in part mediated by NFkB inhibition, ICIS Meeting, online. 2020.
• Islam R, Permousa M, Gordon S, Sviridov D, Freeman L, Pastor R and Remaley A Structure- function studies of apoA-I mimetic peptides for ABCA1-dependent cholesterol efflux and HDL formation, Minneapolis, MN, Annual ATVB Meeting. 2017 .
• Islam M R, Gordon S, Sviridov S, Freeman L and Remaley A. Lipid binding properties of apolipoprotein mimetic peptides designed for cholesterol efflux, Annual NIH Summer Intern Research Day. 2016.
• Islam R and Bloomquist J, Muscle glutamate receptor agonist-induced paralysis in Aedes Aegypti by feeding and intra-thoracic injection assays, University of Florida, Annual Emerging Pathogens Institute Science Day. 2014.
• Islam R and Bloomquist J, Agonists of muscle glutamate receptor induce paralysis in Aedes aegypti larvae by blocking synaptic transmission and depolarizing the membrane potential, University of Florida, Annual Emerging Pathogens Institute Science Day. 2013.
• Islam R and Bloomquist J Agonists of muscle glutamate receptor induce paralysis in Aedes aegypti larvae, University of Florida, Annual Emerging Pathogens Institute Research Day. 2012.
• Islam R and Bloomquist J, A Fluorescence method for screening compounds designed to selectively control the mosquito vector of malaria, Anopheles Gambiae, University of Florida, Annual Emerging Pathogens Institute Science Day. 2011.
• Islam R, Williams S, Koumasidis S, Cichocki J, Fridell Y-W. Expression of mitochondrial uncoupling protein in drosophila dopaminergic neurons attenuates neurotoxin- induced lethality and motor impairment, Chicago, IL, Society for Neuroscience meeting. 2009.
• Islam, R, Kristiansen L, Romani S, Garcia-Alonso L, Hortsch M. Activation of EGF Receptor Kinase by L1-mediated Cell Adhesion, University of Michigan, Ann Arbor, Michigan, Center for Organogenesis Annual International Symposium. 2003.
• Islam, R, Hsu J-C, Hortsch M. The Drosophila Echinoid protein is a heterophilic ligand of L1- type neural cell adhesion molecule Neuroglian, Orlando, FL. Abstract to the 32nd Annual Neuroscience Meeting. 2002.
MAJOR INVITED SPEECHES
• Islam, R, Structure-function study of apolipoprotein mimetic peptides, Waterville Valley, New Hampshire, Gordon Conference. 2018.
• Islam, R, Structure-function study of apolipoprotein mimetic peptides, Minneapolis, Minnesota, Arteriosclerosis, Thrombosis, and Vascular Biology Meeting. 2017. BIBLIOGRAPHY
Peer Reviewed Research Articles
• Gutierrez-Huerta CA, Turner BS, Claudel SE, Farmer N, Islam R, Mitchell VM, Collins BS, Baumer Y, Remaley AT, Powell-Wiley TM. LDL associates with pro-inflammatory monocyte subset differentiation and increases in chemokine receptor profile expression in African Americans. Int J Cardiol. 2022.
• Kosuke Tamura, Nithya P. Vijayakumar, James F. Troendle, Kaveri Curlin, Sam J. Neally, Valerie M. Mitchell, Billy Collins, Yvonne Baumer, Cristhian Gutierrez Huerta, Rafique Islam, Briana S. Turner, Marcus Andrews, Joniqua Ceasar, Sophie Claudel, Kathryn G. Tippey, Shayne Giuliano, Regina McCoy, Jessica Zahurak, Sharon Lambert, Philip Moore, Mary Douglas Brown, Gwenyth Wallen, Tonya Dodge, and Tiffany M. Powell-Wiley. Tailored Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Disadvantaged Metropolitan Washington, D.C. Communities in Step It Up: A Multilevel, Community-based, Technology-enabled Physical Activity Randomized Controlled Trial. BMJ Open. 2020.
• Islam R, Sviridov DO, Drake SK, Tunyi J, Abdoulaeva G, Freeman LA, Pastor RW, Remaley AT. Incorporation of α-methylated amino acids into Apolipoprotein A-I mimetic peptides improves their helicity and cholesterol efflux potential. Biochem Biophys Res Commun. 2020.
• Carlier PR, Chen QH, Verma, DA. Wong M, Mutunga JM, Müller J, Islam R, Shimozono AM, Tong F, Li J, Totrov M, and Bloomquist JR Select β- and branched 1-alkylpyrazol-4-yl methylcarbamates exhibit high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase. Pesticide Biochemistry and Physiology, 2018.
• Islam R, Pourmousa M, Sviridov D, Gordon S, Neufeld E, Freeman L, Perrin Jr. B, Pastor R and Remaley A. Structural properties of apolipoprotein A-I mimetic peptides that promote ABCA1- Dependent cholesterol efflux. Scientific Reports, 2018.
• Clements II J, Islam R, Sun B, Tong F, Gross A, Bloomquist J, Carlier P. N -Mono- and N, N - diacyl derivatives of benzyl and arylhydrazines as contact insecticides against adult Anopheles gambiae. Pesticide Biochemistry and Physiology, 2017.
• Gross A, Islam R, Ali A, Khan I, Kaplancikli Z, Altintop M, Ozdemir A, Bloomquist J. Toxicity and Synergistic Activities of Chalcones Against Aedes aegypti (Diptera: Culicidae) and Drosophila melanogaster (Diptera: Drosophilidae). Journal of Medical Entomology. 2017.
• Gordon S, Pourmousa M, Sampson M, Sviridov D, Islam R, Perrin B, Kemeh G, Pastor R, and Remaley A. Identification of a novel lipid binding motif in apolipoprotein B by the analysis of hydrophobic cluster domains, Biochimica et Biophysica Acta. 2017.
• Larson N, Carlier P, Gross A, Islam R, Ma M, Sun B, Totrov M., Yadav R, and Bloomquist J. Toxicology of potassium channel-directed compounds in mosquitoes. Neurotoxicology. 2016.
• Verma A., Wong D, Islam R, Tong F, Ghavami M, Mutunga J, Slebodnick C, Li J, Viayna E, Lam P, Totrov, M, Bloomquist J, and Carlier P. 3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae. Bioorganic & Medicinal Chemistry. 2015.
• Islam R and Bloomquist J. A method for assessing chemically induced paralysis in headless mosquito larvae. MethodsX, 2015.
• Camerino E, Wong D., Tong F, Korber F, Gross A, Islam R, Viayna E, Mutunga J, Li J, Totrov M, Bloomquist J and Carlier P. Difluoromethyl ketones: Potent inhibitors of wild type and carbamate insensitive G119S mutant Anopheles gambiae acetylcholinesterase. Bioorganic and Medicinal Chemistry Letter. 2015.
• Tong F, Islam R, Carlier, P, Ma M, Ekstrom F, and Bloomquist J. Effects of anticholinesterases on catalysis and induced conformational change of the peripheral anionic site of murine acetylcholinesterase. Pesticide Biochemistry and Physiology. 2013.
• Islam R., Nakamura M, Scott H, Repnikova E, Carnahan M, Pandey D, Caster C, Khan S, Zimmermann T, Zoran M and Panin V. The role of Drosophila cytidine monophosphate- sialic acid synthetase in the nervous system. Journal of Neuroscience. 2013.
• Wong D, Li J, Chen Q, Han Q, Mutunga J, Wysinski A, Anderson T, Ding H, Carpenetti T, Verma A, Islam R, Paulson S, Lam P, Totrov M, Bloomquist J and Carlier P. Select small core structure carbamates exhibit high contact toxicity to "carbamate resistant" strain malaria mosquitoes, Anopheles gambiae (Akron), PLoS One. 2012.
• Islam R, Yang L, Sah M, Kannan K, Anamani D, Vijayan C, Kwok J, Cantino M, Beal M and Fridell, Y-W. A neuroprotective role of the human uncoupling protein 2 (hUCP2) in a Drosophila Parkinson's disease model, Neurobiology of Disease. 2012.
• Islam R., Kumimoto E, Bao H and Zhang B. ALS-linked SOD1 in glial cells enhances ss-N- methylamino L-Alanine (BMAA) induced toxicity in Drosophila. 2012.
• Hartsel J, Wong D, Mutunga J, Ma M, Anderson T, Wysinski A, Islam R, Wong E, Paulson S, Li J, Lam P, Totrov M, Bloomquist J and Carlier P. Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase. Bioorganic and Medicinal Chemistry Letter. 2012.
• Goossens T, Kang Y, Wuytens G, Zimmermann P, Callaerts-Vegh Z, Pollarolo G, Islam R, Hortsch M and Callaerts P. The Drosophila L1CAM homolog Neuroglian signals through distinct pathways to control different aspects of mushroom body axon development. Development. 2011.
• Marozkina N, Yemen S, Borowitz M, Liu L, Plapp M, Sun F, Islam R, Erdmann-Gilmore P, Townsend R, Lichti C, Mantri S, Clapp P, Randell S, Gaston and Zaman K. Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy. Proceedings of the National Academy of Sciences U S A. 2010.
• Islam R, Kristiansen L, Romani S, Garcia-Alonso L and Hortsch M. Activation of EGF receptor kinase by L1-mediated homophilic cell interactions. Molecular Biology of the Cell. 2004.
• Islam R, Wei S, Chiu W, Hortsch M and Hsu J. Neuroglian activates Echinoid to antagonize the Drosophila EGF receptor signaling pathway. Development. 2003. Book Chapters
• Bloomquist J, Mutunga J, Islam R, Verma A, Ma M, Totrov M and Carlier P. Sensitive potassium Kv2 channels as new targets for insecticides. Symposium Series Chapter 6, American Chemical Society. 2014.
• Gross A, Islam R and Bloomquist J Glutamate receptor-cation channel complex: An unexploited target